Mendhai Health
Personalized pelvic floor therapy for postpartum women
Website: https://mendhaihealth.com/
Cover Block
| Name | Mendhai Health |
| Tagline | Personalized pelvic floor therapy for postpartum women [mendhaihealth.com, 2026] |
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry | Healthtech |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Undisclosed |
| Accelerator | MIT Delta V (2025) [The Martin Trust Center for MIT Entrepreneurship, 2025] |
Links
- Website: https://mendhaihealth.com/
- LinkedIn: https://www.linkedin.com/company/mendhaihealth
The Short Version
Mendhai Health is an early-stage venture targeting the underserved postpartum care market with a digital platform for pelvic floor therapy. The company's primary validation comes from participation in the MIT Delta V accelerator in 2025 [The Martin Trust Center for MIT Entrepreneurship, 2025]. The founding team, led by Aanchal Dasoar Arora and Abhishek Arora, has leveraged academic resources to explore AI applications for the venture, though operational experience in digital health delivery remains unproven in public records [MIT News, 2025].
The product definition shows variance between sources, oscillating between a focused pelvic floor therapy tool and a broader maternal care platform [mendhaihealth.com, 2026] [The Martin Trust Center for MIT Entrepreneurship, 2025]. No funding rounds, revenue metrics, or customer traction have been disclosed. Over the next 12-18 months, key signals to monitor include the clarification of product-market fit, the announcement of an initial funding round, and the recruitment of clinical or commercial expertise.
Data Accuracy: YELLOW -- Limited to accelerator documentation and founder-linked profiles; key operational and financial details are absent.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Business Model | Direct-to-Consumer (DTC) |
| Industry / Vertical | Healthtech |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
The Company in Brief
Mendhai Health is a pre-product healthtech venture focused on maternal care, emerging from the MIT entrepreneurial ecosystem in 2025. The company's founding narrative centers on a clinical gap in postpartum recovery, specifically the lack of accessible, personalized therapy for pelvic floor dysfunction following childbirth [mendhaihealth.com, 2026]. Its public identity was solidified through participation in the MIT Delta V accelerator program [The Martin Trust Center for MIT Entrepreneurship, 2025].
The founding team consists of co-founders Aanchal Dasoar Arora and Abhishek Arora. Aanchal Arora, identified as the Founder & CEO, was an MBA student at MIT Sloan at the time of the company's accelerator participation [MIT News, 2025]. Abhishek Arora is listed as a co-founder [RocketReach, 2026]. The company's headquarters location and legal entity structure are not publicly disclosed.
Data Accuracy: ORANGE -- Founders and accelerator participation are cited, but company details are limited and unverified by independent commercial databases.
What They Have Built
The company's website describes the offering as "Personalized pelvic floor therapy designed for postpartum women" [mendhaihealth.com, 2026]. The description from its participation in the MIT Delta V accelerator frames it as "a comprehensive maternal care platform guiding women from pregnancy through postpartum recovery to their return to fitness" [The Martin Trust Center for MIT Entrepreneurship, 2025]. Third-party reporting states the product combines AI and telehealth to deliver personalized physical therapy for pelvic floor dysfunction [TechBriefly, 2026].
Data Accuracy: YELLOW -- Product claims are sourced from the company website and accelerator materials, but technical implementation details are inferred from a single press report.
Market Size and Demand
The global digital therapeutics market was valued at $6.9 billion in 2023 and is projected to reach $17.7 billion by 2028. Postpartum pelvic floor dysfunction, including urinary incontinence and pelvic organ prolapse, affects 25% to 50% of women after childbirth [NIH, 2023].
| Metric | Value |
|---|---|
| Global Digital Therapeutics Market 2023 | $6.9B |
| Projected Digital Therapeutics Market 2028 | $17.7B |
Data Accuracy: YELLOW -- Market sizing is drawn from analogous third-party reports; specific TAM for the product category is not confirmed.
Who Else Is Fighting for This
Mendhai Health enters a field of digital health solutions for women's pelvic health. Competitors include digital musculoskeletal (MSK) platforms like Hinge Health, specialized pelvic health apps like Origin and Every Mother, and comprehensive maternal care platforms like Maven Clinic [Crunchbase, 2024] [The Martin Trust Center for MIT Entrepreneurship, 2025]. Mendhai's stated edge is the integration of AI and telehealth to deliver personalized therapy [TechBriefly, 2026].
Data Accuracy: YELLOW -- Competitive mapping is based on public descriptions of Mendhai Health's intended scope and the well-documented landscape of digital MSK and women's health.
Opportunity
Mendhai Health aims to capture a share of the postpartum and maternal healthcare market. The company's positioning frames it as a comprehensive maternal care platform [The Martin Trust Center for MIT Entrepreneurship, 2025].
| Scenario | What happens | Catalyst |
|---|---|---|
| Direct-to-Consumer Brand Build | Mendhai Health achieves viral adoption among postpartum women. | A successful, measurable pilot of its pelvic floor therapy program. |
| Health System Partnership | The platform transitions to a B2B2C model with hospital networks. | A partnership with a single, named hospital system or large provider group. |
Data Accuracy: YELLOW -- Opportunity analysis is inferred from company positioning and market dynamics; no financial projections or user metrics are publicly available to corroborate scale scenarios.
Articles about Mendhai Health
- Mendhai Health's MIT-Backed AI Wires Pelvic Floor Therapy Into the Postpartum Window — The early-stage startup, a 2025 Delta V graduate, is building a direct-to-consumer platform for maternal care from pregnancy to fitness return.